Table 3.
Dosage, Process, and Outcomes Measures
| Dosage components* | Mean (SD) per patient per year | Number of patients | Baseline | Study | Change |
|---|---|---|---|---|---|
| Amount, minutes | 203.5 (268.2) | ||||
| Direct time | 97.1 (146.1) | ||||
| Face to face | 71.7 (130.5) | ||||
| Calls | 25.3 (41.8) | ||||
| Indirect time | 106.4 (142.1) | ||||
| Frequency (number of services) | 4.3 (6.4) | ||||
| Duration (days of follow-up) | 112.1 (104.4) | ||||
| Breadth† | 2.6 (1.2) | ||||
| Dosage summary (factors) | 0.0 (1) | ||||
| Process (%) | |||||
| HbA1c testing adherence | 768 | 50.0 | 70.2 | +20.2 | |
| LDL testing adherence | 1,223 | 65.0 | 76.0 | +11 | |
| Outcomes, mean (SD) | |||||
| HbA1c levels (%) | 539 | 8.2 (2.1) | 7.1 (1.6) | −1.1 (2.0) | |
| LDL levels (mg/dL) | 693 | 187 (50) | 155 (56) | −32.5 (63) |
*Calculated from 10,194 completed encounters
†Breadth was the count of the following service categories: education, motivation, following protocols, communication/collaboration, community advocacy, and coordinating activities.